Mersana Therapeutics, Inc. Contract with Customer, Asset, after Allowance for Credit Loss
Mersana Therapeutics, Inc. had Contract with Customer, Asset, after Allowance for Credit Loss of $0 as of 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Balance Sheet › Assets
us-gaap:ContractWithCustomerAssetNet · last filed 2023-11-07
- 2023-09-30: Contract with Customer, Asset, after Allowance for Credit Loss $0.00.
- 2022-09-30: Contract with Customer, Asset, after Allowance for Credit Loss $0.00.
- 2021-12-31: Contract with Customer, Asset, after Allowance for Credit Loss $0.00.
- 2021-09-30: Contract with Customer, Asset, after Allowance for Credit Loss $0.00.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss |
|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 |
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-06 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 |